<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>DEGs identified in KEGG pathway: Calcium signaling. Differential expression indicates the average log
   <sub>2</sub>-fold change in RNA-Seq transcript levels from three independent experiments at each sampling period: D7 vs D0, D13 vs D7, D18 v D13, and D28 v D18. The 
   <italic>p</italic>-values were ≤ 0.001. Negative log
   <sub>2</sub>-fold change corresponds to gene downregulation and the positive values indicate gene activation
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="4">Calcium signaling pathway</th>
   </tr>
   <tr>
    <th>Gene ID</th>
    <th>Description</th>
    <th>Differential expression</th>
    <th>Time</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>HTR7</td>
    <td>5-hydroxytryptamine receptor 7</td>
    <td>−5.492892685</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CACNA1B</td>
    <td>voltage-dependent calcium channel N type alpha-1B</td>
    <td>−1.834598101</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>CXCR4</td>
    <td>C-X-C chemokine receptor type 4</td>
    <td>4.604478969</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ADCY2</td>
    <td>adenylate cyclase 2</td>
    <td>−3.460253861</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>STIM1</td>
    <td>stromal interaction molecule 1</td>
    <td>1.834422349</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>VDAC1</td>
    <td>voltage-dependent anion channel protein 1</td>
    <td>−1.32731076</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>GNA14</td>
    <td>guanine nucleotide-binding protein subunit alpha-14</td>
    <td>−5.014275635</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>TRDN</td>
    <td>Triadin</td>
    <td>−4.320486512</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>RYR2</td>
    <td>ryanodine receptor 2</td>
    <td>−4.07053211</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>RYR3</td>
    <td>ryanodine receptor 3</td>
    <td>1.71133494</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ITPR2</td>
    <td>inositol 1,4,5-triphosphate receptor type 2</td>
    <td>−3.699823272</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ITPR3</td>
    <td>inositol 1,4,5-triphosphate receptor type 3</td>
    <td>−2.406497059</td>
    <td>D0-D7</td>
   </tr>
   <tr>
    <td>ERBB4</td>
    <td>receptor tyrosine-protein kinase erbB-4</td>
    <td>4.531919812</td>
    <td>D7-D13</td>
   </tr>
   <tr>
    <td>CACNA1B</td>
    <td>voltage-dependent calcium channel N type alpha-1B</td>
    <td>1.88048051</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>CACNA1E</td>
    <td>voltage-dependent calcium channel R type alpha-1E</td>
    <td>3.425325465</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>GRIN2A</td>
    <td>glutamate receptor ionotropic, NMDA 2A</td>
    <td>2.854753149</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>P2RX3</td>
    <td>P2X purinoceptor 3</td>
    <td>2.552456853</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>CAMK4</td>
    <td>calcium/calmodulin-dependent protein kinase IV</td>
    <td>1.41910402</td>
    <td>D13-D18</td>
   </tr>
   <tr>
    <td>CHRM3</td>
    <td>muscarinic acetylcholine receptor M3</td>
    <td>3.978819163</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>HTR7</td>
    <td>5-hydroxytryptamine receptor 7</td>
    <td>3.808433488</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>GRIN1</td>
    <td>glutamate receptor ionotropic, NMDA 1</td>
    <td>3.726336735</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>GRIN2D</td>
    <td>glutamate receptor ionotropic, NMDA 2D</td>
    <td>2.087932817</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>CHRM2</td>
    <td>muscarinic acetylcholine receptor M2</td>
    <td>3.383752478</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>ADRA1A</td>
    <td>adrenergic receptor alpha-1A</td>
    <td>4.207285974</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>TACR3</td>
    <td>tachykinin receptor 3</td>
    <td>2.111829478</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>GRM1</td>
    <td>metabotropic glutamate receptor 1</td>
    <td>3.134222868</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>EGFR</td>
    <td>epidermal growth factor receptor</td>
    <td>−2.084730311</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>GNAL</td>
    <td>guanine nucleotide-binding protein G(olf) subunit alpha</td>
    <td>1.685044809</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>ADCY2</td>
    <td>adenylate cyclase 2</td>
    <td>3.240853085</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>STIM2</td>
    <td>stromal interaction molecule 2</td>
    <td>1.158068159</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>RYR2</td>
    <td>ryanodine receptor 2</td>
    <td>4.896050853</td>
    <td>D18-D28</td>
   </tr>
   <tr>
    <td>PRKCB</td>
    <td>classical protein kinase C beta type</td>
    <td>1.642454101</td>
    <td>D18-D28</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
